Showing results (1581-1590 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|July 24, 2026
A PTX3/TLR4 axis sustains SHH-Medulloblastoma growth and defines a new therapeutic vulnerabilitySerena Filiberti, Camilla Tavani, Elena Somenza, et al.
Neuro-Oncology|March 19, 2023
Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptakeDanling Gu, Fengqi Zhou, Hao You, et al.
Neuro-Oncology|July 21, 2026
The CoREST complex inhibitor, corin, decreases tumor growth, increases cellular differentiation and extends lifespan in ATRT xenograft modelsAnupa Geethadevi, Nikhil Vaidya, Robert J Fisher, et al.
Neuro-Oncology|August 10, 2026
Potent anti-tumor preclinical efficacy of B7-H3 CAR-T cells in H3G34-mutant, Diffuse Hemispheric GliomaDavid Akhavan, Monika Yadav, Siddharth Subham, et al.
Neuro-Oncology|August 11, 2026
How 'Sturgeon' guides the surgeon in pediatric neuro-oncologyMariska Sie, Oscar H J Eelkman Rooda, Mariëtte E G Kranendonk, et al.
Neuro-Oncology|August 14, 2026
PET RANO 1.0 vs. RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: a retrospective, comparative studyKatharina J Schmidbauer, Isabelle von Polenz, Jonas Reis, et al.
Neuro-Oncology|August 19, 2026
Abexinostat attenuates temozolomide-resistant glioma stem cellsBalaji Perumalsamy, Raghupathy Vengoji, Anand Thiraviyam, et al.
Neuro-Oncology|August 20, 2026
ESTRO, ESNR and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumoursLieselotte Lauwens, Catharina M L Zegers, Alida A Postma, et al.
Neuro-Oncology|September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Neuro-Oncology|December 24, 2014
Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine gliomaNathalène Truffaux, Cathy Philippe, Janna Paulsson, et al.
Pageof 316